Zimbabwe has declined a substantial US health deal worth 367 million US dollars (272 million pounds) over five years due to Washington's demand for confidential information.
The decision became public following a government memo dated December was leaked, indicating that President Emmerson Mnangagwa believed the arrangement was "skewed".
A government spokesperson later explained that the United States was demanding access to health data for research and commercial gain while was not willing to share the resulting advantages from future vaccines.
"We are forced to start the difficult and regrettable process of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had donated over $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for more negotiations to find a agreement agreeable to all parties so the nation's vital HIV programme can be sustained.
Broader Context
This development follows a comparable situation in neighbouring Kenya, where a high court blocked a related health funding agreement after concerns were raised about the security of Kenyans' health data.
Since resuming office last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had administered assistance for the US government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to boost openness and responsibility.
As per reports, 16 nations in Africa have to date agreed to similar agreements, representing over $18.3bn in new funding.
Details of the Rejected Deal
The money for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation might have yielded significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on HIV treatment through US-supported initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, with no corresponding promise of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," Mangwana explained.
"Put simply, our country would provide the raw materials for scientific discovery without any assurance that the final treatments would be available to our population if a future health crisis emerge."
Sovereignty and International Frameworks
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining frameworks previously set up through the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing framework created to deal with future pandemics.
"This mechanism is designed to guarantee that when a country provides its data, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We welcome continued dialogue with our US partners on how future collaboration could be arranged in a manner that honours the sovereignty and dignity of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but suggested that negotiations should continue given that much of the country's Aids initiatives depended on external financing.
"Where specific concerns exist, including those relating to information security or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," it added.
The situation underscores the ongoing tensions between accepting much-needed international aid and safeguarding national sovereignty in an increasingly data-driven world.